Launched in February 2005, Google Maps is now used by over 1 billion people every month. There is no other mapping service that even comes close to the dominance of Google Maps.
So how did it get there?
saying that Alphabet (NASDAQ:GOOGNasdaq:Google), Google’s parent company, has some control over the Internet, that would be a huge understatement. The company has been the leading search engine for nearly two decades, making up 90% of all Internet searches. Google literally decides where to direct Internet users every time they look for something (a scary thing if you think about it).
Bing is second only to Google, with only 6% of search traffic. Google basically has no competitors when it comes to search.
Of course, Google’s search algorithms are incredibly good… but its suite of products and services is what really sets Google apart.
Some of its companies, such as YouTube, stand alone as their own brands.
However, most of the company’s tools, such as Maps, are branded as Google products.
But don’t be a fool. That doesn’t mean that Google has created the entire Maps platform.
Instead, it acquired smaller companies like Waze, and then combined the technologies to make the Google Maps service so useful.
Since 2001, Alphabet has announced acquisitions of approximately 250 private companies. These acquired companies have been integrated into Google’s ecosystem to further build on its dominance of the Internet.
In fact, Alphabet acquired at least a dozen private companies just for the sake of Google Maps services.
Look where am I going here?
By observing the acquisition trends of major companies, we can not only look to the future to see where the trends are headed, but also to position ourselves as investors on a path of progress.
That’s exactly what we’re going to do today. (Plus, I’m going to share a brand new personal investment opportunity, including a link to its crowdfunding page.)
But first, let’s take a look at what the major tech companies are getting into right now.
Big Tech Takes on Healthcare
Alphabet, Amazon (NASDAQ:AMZN), Apple (NASDAQ:AAPL), Microsoft (NASDAQ:MSFT), and other big tech companies making their way into the healthcare world.
While this has been happening for the past several years… it has been intensifying recently.
The world of venture capital has taken note. VCs and angel investors are pouring money into healthcare companies that are prime acquisition targets for big tech.
As per the report of CB Insights,
“With the vast amount of data available, there is a rapidly growing opportunity for digital solutions in drug discovery pharma. Funding to AI drug discovery companies reached a record high in 2020, with an investment of approximately $1.3 billion. The record has already been broken in 2021, with $2.6 billion raised so far.
While artificial intelligence (AI) drug discovery may seem typical, it is the bigger picture that is important to understand.
For example, you can now monitor heart rate, temperature, sleep patterns, and all kinds of health trends from your Apple Watch.
Google, which acquired Fitbit in January for $2.1 billion, also sees huge opportunities.
Rick Osterloh, Google’s senior vice president of devices and services, had this to say about the acquisition:
“Technology can change the way people manage their health and well-being, and this is especially important these days. We work to create new tools and services that help increase your knowledge, success, health and happiness. will work together.”
PillPack, which Amazon acquired in 2018 for $753 million, is another example of Big Tech making its way into healthcare. Amazon has made it easier for many people to gain access to prescription drugs, as well as gaining an incredible database of market trends and behaviors.
ground level: Big Tech is laying the groundwork to be an integral part of our global healthcare system, and this week one of the biggest deals ever…
Data is the future of healing
on Monday, Oracle (NYSE:orcl) announced that it is acquiring the health technology company kerner for $28.3 billion cash, Cerner, specializing in electronic health records (EHR), could become a tremendous asset to Oracle.
as reported by wall street journal,
“Enterprise tech providers’ entry into the medical records space is meant to accelerate the creation of a 360-degree view of a patient. Success depends on the ability to connect devices that allow different electronic systems to talk to each other , allow for bridging information hosted in the cloud or on corporate data centers…”
Oracle, the world’s second largest software company, could soon become an extremely strategic partner for other tech companies. Consumer electronics companies, such as Apple, can make their smart watches more than simple devices that show your heartbeat.
Imagine if you could figure out if you wear a device on your wrist (or on your finger, like an Aura Ring) that you’re going to have a heart attack before it even happens…
In preparation, you may be directed to go to the nearest hospital, where a complete cardiac team is waiting for you with all your medical records… ready to treat a life-threatening event before it happens.
This is where Big Tech is headed — and where they will continue to make private company acquisitions.
If you think Big Tech is an integral part of your life now, wait until your life really depends on them…
Next Biotech Acquisition?
It’s not just about Big Tech shutting down private health companies. Of course big pharma companies acquire smaller biotech startups.
Because of this, biotech startups — especially those with defensive intellectual property (IP) — can turn into big wins for us as private investors.
And today I want to introduce you sen-jamo pharmaceutical,
sen-jamo Has an impressive IP portfolio. The Huntington, NY-based company currently has 25 patents and patents pending:
- a verbal COVID-19 medical
- an opioid withdrawal treatment
- and an alcohol hangover preventative
Although those three conditions seem unrelated, they are all treatable with anti-inflammatory drugs — which is what Cen-Jam focuses on.
Earlier this month, Cen-Jam partnered with Duke University to begin clinical trials for its oral COVID-19 medical treatment. Any success with this test could be a game changer for the company (and that’s an understatement).
But I think two other possible treatments of sen-jame might be more appealing…
Let me tell you why this is true and present all the details on how to invest in Sen-Jam Top 3 Private Investments for 2022 Report, which I just updated to include this new deal.
I’ll update that report each time one of my highlighted private company deals expires – and as a member Venture Capital DigestYou’ll be the first to know.
You can get all the details including how to join here.
At the date of publication, Cody Shirk had no position (directly or indirectly) in the securities mentioned in this article. The views expressed in this article are those of the author, who is subject to InvestorPlace.com Publication Guidelines,
By focusing on megatrends shaping the future, Cody Shirk uncovers generational wealth in the private investment sector. To make sure you never miss Venture Capital Digest, click here to subscribe.